One‐Year Outcomes After Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke: A Real‐World Study

Documenti analoghi

• Association of Early Blood Pressure Levels and Outcomes in Ischemic Stroke Treated With Intravenous Thrombolysis: A Prospective Cohort Study
  di: Luyi Zhu, et al.
  Pubblicazione: (2025)
• Development and Validation of Multiple Machine Learning Models Integrating Neutrophil‐Lymphocyte Ratio for Prediction of Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke
  di: Fanhai Bu, et al.
  Pubblicazione: (2025)
• Emergency Admission Plasma D‐Dimer and Prothrombin Activity: Novel Predictors for Clinical Outcomes After Thrombectomy in Acute Ischemic Stroke With Large Artery Occlusion
  di: Shandong Jiang, et al.
  Pubblicazione: (2025)
• The Dopamine Transporter Is a New Target for Ischemic Stroke
  di: Yan‐Qiong Cheng, et al.
  Pubblicazione: (2024)
• Examining the Impact of Microglia on Ischemic Stroke With an Emphasis on the Metabolism of Immune Cells
  di: Jing Lv, et al.
  Pubblicazione: (2025)